Full-Time

Contract Research, Development, and Manufacturing Organization (CRDMO) Program Lead

Updated on 5/26/2026

GeneFab

GeneFab

Compensation Overview

$175k - $215k/yr

Alameda, CA, USA

In Person

Category
Business & Strategy (1)
Required Skills
Risk Management
Requirements
  • Bachelor’s degree in Life Sciences, Bioengineering, Chemical Engineering, or related field
  • 5–8+ years of CMC program management experience in biotech, pharma, or cell and gene therapy across the full CMC lifecycle
  • Experience supporting IP, IND, BLA, MAA, or IMPD submissions
  • Track record leading cross-functional product development projects (Synthetic Biology, Process Development, Analytical Development, Manufacturing, Quality Control)
  • Proficiency with Smartsheet Advanced, Think-Cell, and integrated scheduling platforms
  • Strong ability to lead without direct authority in a matrixed, shared-accountability environment; excellent communication, facilitation, and negotiation skills
  • High adaptability and emotional intelligence; comfortable with fast-paced, distributed, cross-functional settings
Responsibilities
  • Lead the workstream within the Integrated Project Team, co-owning program outcomes with Synthetic Biology, Process Development, Analytical Development, MSAT, Quality Control, GMP Manufacturing, Regulatory Affairs, Finance and sponsor partners
  • Facilitate IPT working sessions and Joint Steering Committee meetings; frame decisions with full context, scenario analysis, and downstream impact
  • Champion IPD principles: shared risk/reward, open-book collaboration, and joint decision-making across all workstreams
  • Drive escalation to governance committees at the right level and time; iterate on PMO frameworks, risk registers, and project review boards to improve oversight
  • Lead end-to-end program execution, including therapeutic design, process and analytical development, pivotal readiness, method qualification/validation, pilot & engineering run strategies, and regulatory submission readiness
  • Drive cross-functional alignment across SynBio, PD, Analytical Development, MSAT, QC, and GMP Manufacturing to ensure process consistency, data integrity, and regulatory compliance
  • Translate technical data into program decisions with clear traceability to Target Product Profiles, Critical Quality Attributes, Critical Process Parameters, and regulatory expectations
  • Orchestrate knowledge transfer at key project stages, including onboarding new intellectual property, technology transfer from PD to GMP Manufacturing, and handoffs between customers and internal teams and third party partners in real time
  • Co-lead CMC regulatory strategy with Regulatory Affairs; own the CMC content roadmap and ensure data packages are submission-ready for IND, IMPD, BLA/MAA, or applicable filings
  • Serve as primary point of contact for sponsors and clients; lead integration sessions that bring sponsor teams into the delivery process as active IPD participants
  • Manage scope, deliverables, and expectations; lead change order and scope modification discussions in collaboration with Business Development and technical leads
  • Track program budgets, resource forecasts, and milestone-based invoicing using IPD cost-transparency practices for real-time financial visibility
  • Identify, quantify, and manage technical, regulatory, and timeline risks; develop scenario-based mitigation strategies and advocate for resources as needed
Desired Qualifications
  • Advanced degree (MBA, Master of Science, or Doctor of Philosophy) in a related field
  • PMP certification, IPD, Lean, or Alliance Management training
  • Demonstrated experience leading programs in an IPD, alliance management, or co-development model; CRDMO/sponsor partnership experience strongly preferred

Company Size

N/A

Company Stage

N/A

Total Funding

N/A

Headquarters

N/A

Founded

N/A

Simplify Jobs

Simplify's Take

What believers are saying

  • RegCell partnership accelerates U.S. clinical trials for autoimmune hepatitis.
  • Alameda expansion adds 45,000 sq ft for pivotal trials by 2026.
  • ASGCT 2024 presentations showcase GeneFab's genetic design leadership.

What critics are saying

  • RegCell terminates GeneFab partnership, shifts to Kincell Bio in February 2026.
  • Kincell Bio partnership erodes GeneFab's RegCell manufacturing revenue immediately.
  • Lonza and Thermo Fisher capture GeneFab's clients within 12-18 months.

What makes GeneFab unique

  • GeneFab provides end-to-end CRDMO services for Treg therapies at Alameda facility.
  • 92,000 sq ft site features seven GMP clean rooms for tech transfer and scale-up.
  • Synthetic biology expertise enables co-development of next-gen Treg therapies.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

401(k) Retirement Plan

Flexible Work Hours

Hybrid Work Options

Remote Work Options

Paid Vacation

Paid Sick Leave

Paid Holidays

Paternity Leave

Maternity Leave

Professional Development Budget

Conference Attendance Budget

Wellness Program

Mental Health Support

Phone/Internet Stipend

Home Office Stipend

Stock Options

Company Equity

Family Planning Benefits

Fertility Treatment Support

Adoption Assistance

Parental Leave

Relocation Assistance

Meal Benefits

Employee Referral Bonus

Tuition Reimbursement

Legal Services

Childcare Support

Elder Care Support

Gym Membership

Commuter Benefits

Performance Bonus

Profit Sharing

Employee Stock Purchase Plan

Training Programs

Tuition Reimbursement

Company News

Contract Pharma
May 7th, 2025
GeneFab & RegCell Partner for Treg Therapy Manufacturing in the U.S.

GeneFab, a cell and gene therapy-focused contract research, development, and manufacturing organization (CRDMO), has partnered with RegCell, a biotech company advancing regulatory T cell (Treg) therapies for autoimmune diseases, to support the tech transfer and clinical manufacturing of RegCell's Treg platform as it transitions from Japan to GeneFab's manufacturing facility in Alameda.